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H
istones are basic proteins that are responsible for
packaging genomic DNA into a higher-ordered
structure termed chromatin. The fundamental
repeating unit of chromatin is the nucleosomal core
particle that comprises an octamer of two copies
each of the histones H2A, H2B, H3, and H4, around which is
spooled 150 base pairs of DNA.1 Nucleosomes can be
arrayed into hierarchical architectures that efficiently con-
dense DNA within the nucleus, thus governing access to the
DNA template. One mechanism by which chromatin struc-
ture can be altered involves post-translational modifications
of histones. The 1960s and 1970s witnessed the discovery of
numerous histone modifications, including acetylation,2 lysine
methylation,3 arginine methylation,4 phosphorylation,5,6 and
ubiquitination.7,8 The majority of these modifications cluster
in the N-terminal tails of the core histones and the C-terminal
tails of histones H2A and H2B (Figure 1). Throughout the
1960s to the 1980s, studies by multiple groups yielded circum-
stantial data implicating histone modifications in gene regula-
tion, DNA replication, and other genomic processes, but
the precise functions of these modifications remained largely
enigmatic.
The 1990s represented a period of major milestones in
elucidating the biological roles of histone modifications.
The turning point in this field was the discovery and
characterization of the first histone acetyltransferases9–11 and
deacetylases12 that had been previously characterized as tran-
scriptional regulators, thus providing the first direct links
between histone modifications and gene regulation. These
discoveries were followed in rapid succession by the identifi-
cation of other classes of histone modifying enzymes,
including ubiquitinases,13 arginine and lysine methyltransfer-
ases,14–18 lysine demethylases,19,20 and protein arginine dei-
minases that hydrolyze arginine to citrulline.21,22 Concomi-
tant with these discoveries, numerous families of effector
proteins were identified that recognize specific modification
states to mediate signal transduction in transcriptional regu-
lation, DNA replication, repair, and recombination, and
other nuclear processes.23 Together, these studies have pro-
vided a conceptual foundation for understanding the biolog-
ical functions of histone modifications.
This issue of Biopolymers features a series of reviews that
explore recent advances in our understanding of the struc-
tures, mechanisms, and regulation of chromatin modifying
enzymes and the functions associated with various histone
modification states. Yuan and Marmorstein summarize
histone acetyltransferase structure and regulation by autoace-
tylation and describe the widespread nature of protein
acetylation, drawing comparisons to protein kinases and
phosphorylation. In a complementary review, Fierke and
colleagues examine the substrate specificity, catalytic mecha-
nism, and regulation of metal-dependent histone deacety-
lases, focusing on studies of HDAC8. Two reviews explore
topics pertaining to lysine methylation. Black and Whetstine
provide a comprehensive overview of the different biological
functions associated with histone lysine methylation and the
biochemical basis by which methylation status is controlled
through the concerted activities of lysine methyltransferases
and demethylases. In a related article, Couture and colleagues
explore the structure, assembly, and regulation of the
MLL1/SET1 complexes that methylate Lys4 in histone
H3. Garza and Pillus round out the reviews on lysine modifi-
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cations by providing a perspective on SUMO-Targeted Ubiq-
uitin Ligation (STUbL), focusing on enzymes that display
STUbL activity and their chromatin-related functions.
Finally, Bicker and Thompson review protein arginine deimi-
nases, their roles in chromatin modifications and links to
various diseases, and the development of small molecule
inhibitors as cellular probes to study their functions.
A common theme that emerges in these articles is that
post-translational modifications are not confined to histones
but are prevalent in many nonhistone proteins. Indeed,
many nuclear proteins have been shown to undergo a multi-
tude of modifications analogous to histones, particularly
transcription factors, as exemplified by the tumor suppressor
p53.24,25 Correlatively, many modifying enzymes initially
categorized as histone-specific have since been shown to pos-
sess nonhistone substrates and functions beyond chromatin
modification. Collectively, these findings illustrate the com-
plexity of post-translational modifications in nuclear signal
transduction. Efforts to characterize these signaling pathways
are fundamentally important to understanding the physio-
FIGURE 1 Crystal structure of the nucleosome core particle (PDB accession code: 3AFA)
with representative N- and C-terminal tails of the core histones modeled in a fully extended con-
formation. Key modified residues are labeled, and their modifications are denoted by color.
Methylated lysine residues can occur in mono-, di-, and trimethylated states, whereas methylated
arginine residues can be potentially monomethylated, symmetrically dimethylated, and asym-
metrically dimethylated. This figure was rendered using PyMOL (Schrödinger, LLC).
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logical functions of post-translational modifications of nu-
clear proteins and how dysregulation of these pathways
contributes to the incidence of various diseases, particularly
cancer.
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